Pathogenesis of chronic liver injury and hepatocellular carcinoma in alpha-1-antitrypsin deficiency.
about
New advances in hepatocellular carcinomaLiver tumors in children with metabolic disordersCapitalizing on the autophagic response for treatment of liver disease caused by alpha-1-antitrypsin deficiency and other genetic diseasesThe delicate balance between secreted protein folding and endoplasmic reticulum-associated degradation in human physiologyDeficient and Null Variants of SERPINA1 Are Proteotoxic in a Caenorhabditis elegans Model of α1-Antitrypsin DeficiencyGenetic modifiers of liver disease in cystic fibrosis.Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells.Z α1-antitrypsin confers a proinflammatory phenotype that contributes to chronic obstructive pulmonary diseaseA novel monoclonal antibody to characterize pathogenic polymers in liver disease associated with alpha1-antitrypsin deficiency.A genome-wide RNAi screen identifies potential drug targets in a C. elegans model of α1-antitrypsin deficiency.Quantitative proteomic analyses of cerebrospinal fluid using iTRAQ in a primate model of iron deficiency anemia.The association of family history of liver cancer with hepatocellular carcinoma: a case-control study in the United States.Proteomic analysis of differentially expressed proteins in peripheral cholangiocarcinoma.Role of autophagy in liver physiology and pathophysiology.Z α-1 antitrypsin deficiency and the endoplasmic reticulum stress response.The aggregation-prone intracellular serpin SRP-2 fails to transit the ER in Caenorhabditis elegans.Genome-level analysis of genetic regulation of liver gene expression networks.Functions of autophagy in hepatic and pancreatic physiology and disease.Liver repopulation and carcinogenesis: two sides of the same coin?UDP-glucose:glycoprotein glucosyltransferase (UGGT1) promotes substrate solubility in the endoplasmic reticulum.Autophagic disposal of the aggregation-prone protein that causes liver inflammation and carcinogenesis in alpha-1-antitrypsin deficiency.Single nucleotide polymorphism-mediated translational suppression of endoplasmic reticulum mannosidase I modifies the onset of end-stage liver disease in alpha1-antitrypsin deficiency.Modeling molecular and cellular aspects of human disease using the nematode Caenorhabditis elegans.Novel treatment strategies for liver disease due to α1-antitrypsin deficiency.Chemotherapy for Hepatocellular Carcinoma: Current Evidence and Future PerspectivesCharacteristics of hepatocellular carcinoma in a murine model of alpha-1-antitrypsin deficiency.Dysfunctional glycogen storage in a mouse model of alpha1-antitrypsin deficiency.Real time PCR detection of the PI*Z and PI*S mutations associated with alpha-1 antitrypsin deficiencyNew insight into serpin polymerization and aggregation.Regulator of G Signaling 16 is a marker for the distinct endoplasmic reticulum stress state associated with aggregated mutant alpha1-antitrypsin Z in the classical form of alpha1-antitrypsin deficiency.Alpha-1-antitrypsin deficiency: from genoma to liver disease. PiZ mouse as model for the development of liver pathology in human.
P2860
Q26749329-0F1D3725-9282-4B51-B5AD-89488D972F63Q26770292-399243DA-1D9C-43DC-9A4C-1DE47AD446A9Q26862688-35C1696A-A921-41DD-988D-7F749A518A15Q27015793-BD9865FF-C3E7-45A0-91A5-76951464A54BQ27348851-6B525EC6-DDF2-4402-A661-14538FD61555Q30418279-32B7317D-05D4-4A04-BB38-331BF4C087C7Q33672762-44768796-B3C6-4558-B31A-89ADDDA51DACQ33901639-A5A73518-CCE4-410B-811A-9E265ABFE5D2Q34123062-B5473B82-8C36-4DC8-B9D2-DA92A797F77EQ34155401-C95C06C3-F48D-4FEC-A5FD-BDB9D07DE7CCQ34423339-F356BE95-D142-49A4-9494-66E26F1CB179Q34601654-EC9193F4-6DA2-4176-A549-10D5D57BEA1CQ34618992-5A0B3CCE-3E24-45CE-8970-EAAF5299C5EBQ34878438-CC82B239-9231-43CB-A99E-39DE674B20EAQ34962759-4F3D7F8E-4B28-4714-8FE7-C4D1908AF8F0Q35579793-3BFD1674-A899-4382-BC18-B3D77BB6C2D1Q36457518-619A879A-3146-4FD2-893E-CD750F302C29Q36948885-8A8F319C-669E-4BB8-AD57-86F0B5966626Q37102829-16DB382D-3B54-499E-9ED7-3EB0B4C0D20EQ37131458-0F1E3B3A-9510-40AD-9C0A-FB9AB4283D3DQ37212761-9DB13F96-82C9-4DAD-8F35-119217737E5EQ37249690-C4E9FE2E-CBA3-4783-87E1-C13C76228ED1Q37293096-C6019AB6-919E-4DF7-A9FC-E4EF102387A8Q38017699-71E0A9AD-7489-4496-9368-729C67CEF6B3Q41706847-542AB2AC-87BD-4954-A387-865576C65874Q41863956-9AD53ED1-5707-4FF4-8FC6-4395A9274BDCQ41891765-7DC59EE4-7845-4445-8DDE-1BCB84C999BAQ41942630-05BA8246-9345-406D-B56E-7139ABDD9224Q43135777-017F0894-FDDB-4B66-824E-3DCC69804756Q53330981-C4FE931D-08CB-423A-832F-32B7D99B877CQ54222676-2899BECD-8129-4550-9B4E-750E020E8D73
P2860
Pathogenesis of chronic liver injury and hepatocellular carcinoma in alpha-1-antitrypsin deficiency.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Pathogenesis of chronic liver ...... lpha-1-antitrypsin deficiency.
@ast
Pathogenesis of chronic liver ...... lpha-1-antitrypsin deficiency.
@en
type
label
Pathogenesis of chronic liver ...... lpha-1-antitrypsin deficiency.
@ast
Pathogenesis of chronic liver ...... lpha-1-antitrypsin deficiency.
@en
prefLabel
Pathogenesis of chronic liver ...... lpha-1-antitrypsin deficiency.
@ast
Pathogenesis of chronic liver ...... lpha-1-antitrypsin deficiency.
@en
P2860
P1433
P1476
Pathogenesis of chronic liver ...... lpha-1-antitrypsin deficiency.
@en
P2093
David H Perlmutter
P2860
P304
P356
10.1203/01.PDR.0000228350.61496.90
P407
P577
2006-08-01T00:00:00Z
P5875
P6179
1023172401